PFE · News · 20260921N
Cost Realignment Program
PFIZER INC · 2026-09-21 · Importance 64 · Surprise 42 · No source text
Pfizer targets $9.7 billion in cost savings by 2029. The savings program is intended to support dividend coverage through the company’s patent cliff. Pfizer also expects the savings to preserve funding for research and development investment.
Key facts
- Management targets $9.7B in cost savings by 2029. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | positive | probable | +32.3% | Management targets $9.7B in cost savings by 2029. |